Clinical Trials Browser

Withdrawn × atezolizumab × Tumor-Agnostic × Clear all

NCT06762808 2025-08-15

Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC

Phase 2 Withdrawn

Carcinoma, Squamous Cell

NCT06416436 2025-06-29

Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients

Phase 1 Withdrawn

Neoplasm Metastasis